Ryan Ashlock promoted within Adventist Health, hunt for new Castle president and CEO underway
Ryan Ashlock to remain part of Adventist Health Castle "to facilitate a smooth leadership transition." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 27, 2024 Category: Biotechnology Authors: Kelsey Kukaua Medeiros Source Type: news
IO Biotech Board Member Jack Nielsen Resigns Due to Health
https://www.tipranks.com/news/company-announcements/io-biotech-board-member-jack-nielsen-resigns-due-to-health?utm_source=biztoc.com&utm_medium=referral (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
Aptiva Health opens new mental health clinic
The clinic is Aptiva Health's 10th location in Kentucky. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Joel Stinnett Source Type: news
AbbVie looks to Skyrizi, other drugs to replace blockbuster Humira sales
Sales of Skyrizi and Rinvoq jumped in the first quarter for AbbVie, while Humira sales slid. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Ben Miller Source Type: news
Medical network to invest $25M into Dayton-area college
A Dayton medical network will invest millions into a local university. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Benjamin Weaver Source Type: news
Centene updates full-year guidance in Q1 earnings report
The Clayton-based corporation increased its full-year adjusted diluted earnings per share guidance floor by 10 cents to greater than $6.80. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: James Drew Source Type: news
Medical lab owner from Aventura charged in alleged $36M fraud scheme
The alleged targeted federal agencies included Medicare and the Health Resources and Services Administration (HRSA) Covid-19 Uninsured Program. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Eman Elshahawy Source Type: news
Mass. health czar: State is 'prepared' for whatever comes next with Steward
Health and Human Services Secretary Kate Walsh acknowledged to the Senate Post Audit and Oversight Committee that receivership has been discussed for Steward Health Care's local hospitals. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Michael P. Norton Source Type: news
NIH funding in Oregon rose to near $428 million last year
Oregon's research universities and many of its health startups and social service nonprofits depend on federal funding from the NIH. Last year they got a substantial boost in that support. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Brandon Sawyer Source Type: news
CHMP recommends EU approval of Roche ’s Alecensa as the first adjuvant treatment for resected ALK-positive early-stage lung cancer
If approved, Alecensa will be the first and only ALK inhibitor approved for people with resected ALK-positive early-stage non-small cell lung cancer (NSCLC)The positive recommendation is based on results from the Phase III ALINA study where Alecensa showed an unprecedented 76% reduction in the risk of disease recurrence or death, compared to adjuvant chemotherapy1With about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery, Alecensa could minimise the risk by treating NSCLC before it has spread2Basel, 26 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today th...
Source: Roche Investor Update - April 26, 2024 Category: Pharmaceuticals Source Type: news
Cohere Health expands platform to solve the prior-authorization problem
The health insurance tech company says it alleviates the administrative burden on physicians. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Isabel Tehan Source Type: news
Labcorp wins $239M bid for bankrupt firm with huge Triangle site
Labcorp won a bid for a bankrupt biotech company that planned hundreds of jobs at a huge Morrisville facility. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 26, 2024 Category: Pharmaceuticals Authors: Lillian Johnson Source Type: news
Avecho Biotech Welcomes New Director
Avecho Biotechnology Limited (AU:AVE) has released an update. Avecho Biotechnology Limited has announced the appointment of Katherine Ellen Daniell... (Source: Reuters: Health)
Source: Reuters: Health - April 26, 2024 Category: Consumer Health News Source Type: news
Life sciences tools maker to pare 10% of workforce in latest biotech industry cuts
The company over the past two years has tried to pull good-but-underperforming products under one umbrella and in January completed a merger with SomaLogic. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 26, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news
Pharma leads in assigning key managerial roles to women
While female KMPs in the financial services sector were all professional leaders, in pharma, they were promoters, according to data from FY23 collated for ET by executive search firm EMA Partners India.However, Indian companies continue to struggle to have a better gender balance when it comes to KMPs. According to the Companies Act, KMPs are the CEOs or managing directors, chief financial officers, company secretaries and wholetime directors. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 25, 2024 Category: Pharmaceuticals Source Type: news
